| Identification | Back Directory | [Name]
2-(Methylamino-d3)-3',4'-(methylenedioxy)butyrophenone | [CAS]
1231710-63-6 | [Synonyms]
Butylone-d3 hydrochloride
Butylone hydrochloride D3
Butylone hydrochloride salt
[2H3]-Butylone hydrochloride
Butylone-d3 (hydrochloride) (CRM)
Butylone-d3 hydrochloride solution
Butylone-d3 (hydrochloride) (exempt preparation)
2-(Methylamino-d3)-3',4'-(methylenedioxy)butyrophenone
Keto-N-methyl-d3-benzodioxolylpropylamine hydrochloride
1-(1,3-benzodioxol-5-yl)-2-(trideuteriomethylamino)butan-1-one
2-(MethylaMino-d3)-3,4-(Methylenedioxy)butyrophenone Hydrochloride
1-(1,3-Benzodioxol-5-yl)-2-(methyl-d3-amino)-1-butanone hydrochloride
1-(1,3-benzodioxol-5-yl)-2-(trideuteriomethylamino)butan-1-one:hydrochloride | [EINECS(EC#)]
687-316-8 | [Molecular Formula]
C12H16ClNO3 | [MDL Number]
MFCD18910751 | [MOL File]
1231710-63-6.mol | [Molecular Weight]
257.713 |
| Chemical Properties | Back Directory | [Melting point ]
216-220°C (dec.) | [Fp ]
9℃ | [storage temp. ]
Controlled Substance, -20°C Freezer | [solubility ]
soluble in DMSO, Methanol | [form ]
Solid | [color ]
Off-White |
| Hazard Information | Back Directory | [Description]
Butylone-d3 (hydrochloride) (Item No. 9001826) is an analytical reference material intended for use as an internal standard for the quantification of butylone (Item Nos. 10393 | 16059) by GC- or LC-MS. Butylone is categorized as a cathinone. It is a metabolite of bk-DMBDB and has been detected in products sold as bath salts. Butylone-d3 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. | [Chemical Properties]
Off-White Solid | [Uses]
A labelled blocking agent for central | [General Description]
Also known as bk-MBDB or B1, butylone is a new designer drug with significant abuse reported in the US and Europe. This new internal standard is suitable for numerous GC/MS and LC/MS applications from clinical toxicology testing and forensic analysis to urine drug testing and isotope dilution methods. |
|